期刊文献+

CD20阴性弥漫性大B细胞淋巴瘤一例 被引量:1

Diffuse large B-cell lymphoma with negative CD20: a case report
下载PDF
导出
摘要 CD20阴性弥漫性大B细胞淋巴瘤(DLBCL)是一类罕见的侵袭性较强且较难诊断的淋巴增生性疾病,多发于免疫抑制合并病毒感染者。该文报道了1例原发于淋巴结的70岁CD20阴性DLBCL女性患者,其反复发热约半年,左侧颈部淋巴结进行性肿大,质韧,无触痛。首诊考虑为转移性肿瘤,最终由专业的病理医师对颈部淋巴结活组织切片进行复检,行免疫组织化学检查示P63(+++),CD30(+++),LCA(+++),PAX8(+++),P53(90%+),PAX5(+++),MUM1(+),BCL2(+++),BCL6(+++),C-MYC(80%+),Ki-67 (index 30%);分子病理示EBER(散在+),CD20(-),TIA1(-),CD43 (-),EMA (-),CD7 (-),ALK (-),Ber-EP4 (-),CD3 (-),CDX2(-),CK20(-),CK7(-),Napsin A(-),TTF-1(-),WT-1(-),CD10(-),考虑为CD20阴性DLBCL(间变亚型,非生发中心型)。结合影像学、血液学等辅助检查确诊为DLBCL。确诊后予患者CTOD方案(环磷酰胺+地塞米松+吡柔比星)化学治疗,其病情稳定后出院,随后失访。 CD20-negative diffuse large B-cell lymphoma (DLBCL) is a rare and invasive type of lymphoproliferative disease, which is difficult to be diagnosed and primarily occurs in patients with immunosuppression complicated with viral infection. In this study, one female 70-year-old patient diagnosed with CD20- negative DLBCL originating from the lymph nodes was reported. She experienced recurrent fever for approximately half a year, and progressive enlargement in the left cervical lymph nodes with toughening and no tenderness. The patient was suspected with a metastatic tumor during the first diagnosis, and finally diagnosed with lymphoma via biopsy of the cervival lymph nodes by professional pathologists, hnmunohistochemical examination demonstrated P63 (+++), CD30 (+++), LCA (+++), PAX8 (+++), P53 (90% +), PAX5 (+++), MUM1 (+), BCL2 (+++), BCL6 (+++), C-MYC (80% +) and Ki-67 (index 30%). The molecular pathological examination revealed EBER (diffuse + ), CD20 (-), TIA1 (-), CD43 (-), EMA (-), CD7 (-), ALK (-), Ber-EP4 (-), CD3 (-), CDX2 (-), CK20 (-), CK7 (-), NapsinA (-), TTF-1 (-), WT-1 (-) and CD10 (-). The possibility of negative CD20 DLBCL was considered (anaplastic, non-germinal center B-cell-like). The diagnosis of DLBCL was confirmed combined with auxiliary examinations, such as imaging and hematological tests. She received chemotherapy using the CTOD regimen ( cyclophosphamide + dexamethasone + pirobisin) and was discharged after her physcial condition became stable. She was lost to subsequent follow-up.
作者 王樱姿 Wang Yingzi(Department of Ultrasonic Medicine,the Third Affiliated Hospital of Guangzhou Medical University,Guangzhou 510180,China)
出处 《新医学》 2018年第10期762-764,共3页 Journal of New Medicine
关键词 CD20阴性 弥漫大B细胞淋巴瘤 超声检查 免疫组织化学检查 Negative CD20 Diffuse large B-cell lymphoma Ultrasound Immunohistochenlical examination
  • 相关文献

参考文献2

二级参考文献5

  • 1Airio A, Pukkala E, Isomaki H. Elevated cancer inci- dence in patients with dermatomyositis: a population based study. J Rheumatol, 1995, 22: 1300-1303.
  • 2Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyosi- tis: a population-based study. Lancet, 2001, 357: 96- 100.
  • 3Harris NL, Jaffe ES, Diebold J, et al. World Health Or- ganization classification of neoplastic diseases of the hem-atopoietic and lymphoid tissues : report of the Clinical Ad- visory Committee meeting-Airlie House, Virginia, No- vember 1997. J Clin Oncol, 1999, 17: 3835-3849.
  • 4Katzenberger T, Lohr A, Schwarz S, et al. Genetic anal- ysis of de novo CD5 diffuse large B-cell lymphomas sug- gests an origin from a somatically mutated CD5 * progeni- tor B cell. Blood, 2003, 101: 699-702.
  • 5古爱虎,寇克韧,王勇,陈献忠.非霍奇金淋巴瘤患者血清LDH与β_2-MG检测及其临床意义[J].中国临床新医学,2013,6(3):221-223. 被引量:13

共引文献4

同被引文献6

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部